Cell-based Assay Market Projected to Reach US$ 31.4 Billion by 2027 | CAGR of 8.78% – Digital Journal

The latest report by IMARC Group, titled Cell-based Assay Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027, offers a comprehensive analysis of the industry, which comprises insights on the global cell-based assay market. The report also includes competitor and regional analysis, and contemporary advancements in the global market.

The global cell-based assay market reached a value ofUS$ 18.9 Billionin 2021. Looking forward, IMARC Group expects the market to reachUS$ 31.4 Billionby 2027, exhibiting at aCAGR of 8.78%during 2022-2027. Cell-based assay refers to the study of living cells based on their shape and size for pharmaceutical, biotechnological and biochemical applications. It involves extracting living cells from tissues, stem cells and blood samples for evaluating biochemical and functional effects of drug substances, gene activation and cell signaling. It is also utilized for the measurement of cell proliferation, motility, cytotoxicity and morphology that aids in the development of medicinal drugs and diagnosis of various diseases. As a result, it finds extensive applications for producing biologics, conducting cancer research and stem cell analysis using high-throughput screening (HTS) solutions.

We are regularly tracking the direct effect ofCOVID-19on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request Free Sample Report:https://www.imarcgroup.com/cell-based-assays-market/requestsample

Important Attribute and highlights of the Report:

Market Trends:

The global cell-based assay market is primarily driven by significant growth in the pharmaceutical industry. Moreover, the increasing prevalence of diabetes, cancer, neurological and cardiovascular disorders among the geriatric population is enhancing the requirement for cell-based assays for the analysis of various drug compounds. In addition, the widespread utilization of cell-based assays for the detection of coronavirus (Covid-19) infection in the body is providing a thrust to the market growth. Other factors, including significant improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities in the field of biotechnology, are anticipated to drive the market toward growth.

Explore Full Report with TOC & List of Figure:https://www.imarcgroup.com/cell-based-assays-market

Competitive Landscape:

By IMARC group the report has also analyzed the competitive landscape of the market with some of thetop cell-based assay companiesbeing

Some of these key players include:

Key Market Segmentation:

Breakup by Product and Services:

Breakup by Technology:

Breakup by Application:

Breakup by End-User:

Breakup by Region:

Key highlights of the Report:

TOC for the Report:

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Other Reports by IMARC Group:

Data Center Rack Market Report: https://www.imarcgroup.com/data-center-rack-market

Smart Bathroom Market Report: https://www.imarcgroup.com/smart-bathroom-market

Cement Market Report: https://www.imarcgroup.com/cement-manufacturing-plant

Adhesive Tapes Market Report: https://www.imarcgroup.com/adhesive-tapes-market

Aerosol Cans Market Report: https://www.imarcgroup.com/aerosol-cans-market

Aerosol Propellants Market Report: https://www.imarcgroup.com/aerosol-propellants-market

Green Cement Market Report: https://www.imarcgroup.com/green-cement-market

Mobile Mapping Market Report: https://www.imarcgroup.com/mobile-mapping-market

Semiconductor Foundry Market Report: https://www.imarcgroup.com/semiconductor-foundry-market

Smart TV Market Report: https://www.imarcgroup.com/smart-tv-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Contact US

IMARC Group30 N Gould St, Ste RSheridan, WY (Wyoming) 82801 USAEmail: [emailprotected]Tel No:(D) +91 120 433 0800Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Read the original:
Cell-based Assay Market Projected to Reach US$ 31.4 Billion by 2027 | CAGR of 8.78% - Digital Journal